BioSpace News Archive

Novartis Reveals Two Deaths Related to SMA Drug Zolgensma

Two patients receiving Novartis’ SMA gene therapy Zolgensma have died from acute liver failure, the company reported Thursday.

August 12, 2022
·
3 min read
·
Mark Terry
Business

Investor’s Corner: Q2 Pharma & Biotech Insights

CRISPR Therapeutics, Clovis Oncology and VistaGen all released Q2 results this week, while GreenLight Biosciences has some extra cash to work with.

August 12, 2022
·
3 min read
·
Rosemary Scott
FDA-Approved Hypertension Drug Shows Promise in ALS

Scientists from the University of Edinburgh have shown that Terazosin approved for high blood pressure and prostate enlargement could be repurposed for another unlikely indication: ALS.

August 12, 2022
·
3 min read
·
Tristan Manalac
Drug Development

AstraZeneca and Daiichi Sankyo’s Enhertu Racks up Another Clinical Win in Breast Cancer (Updated)

AstraZeneca and Daiichi Sankyo’s Enhertu has been approved by the FDA as the first HER2-directed medicine for the treatment of patients with HER2-mutant metastatic NSCLC.

August 12, 2022
·
4 min read
·
Alex Keown
Business

Kiora Pharmaceuticals Reports First Half 2022 Business Update and Financial Results

August 12, 2022
·
5 min read
FDA

FDA Review: Bayer, Daiichi Sankyo, AstraZeneca and More

Daiichi Sankyo and AstraZeneca report another first-in-class approval for Enhertu, Bayer snags an sNDA in metastatic hormone-sensitive prostate cancer and Merck faces contamination challenges with Januvia.

August 12, 2022
·
3 min read
·
Mark Terry
Drug Development

FDA Action Alert: Provention, bluebird, Amicus and Incyte

This week holds moments of truth for Provention’s type 1 diabetes drug and bluebird bio’s gene therapy for beta-thalassemia. Amicus and Incyte are coming up at the end of the month.

August 12, 2022
·
4 min read
·
Mark Terry
Researchers “Rewire the Brain” to Treat Tinnitus

Researchers have found that the use of a cell phone technology-based polytherapeutic that delivers white noise can improve symptoms for people suffering from tinnitus.

August 12, 2022
·
3 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: Amgen’s Mixed Lumakras Data for Lung Cancer and More

Amgen announced two lung cancer studies with mixed results, Innovent dosed the first patient in a Phase I diabetic macular edema study and HUTCHMED hit the primary endpoint in colorectal cancer.

August 12, 2022
·
5 min read
·
Mark Terry
Study: Implantable Corneas from Pig Skin Restore Vision to Blind

In a small pilot study, the implants were able to restore corneal thickness and curvature to normal levels, and vision outcomes were as good as if human-donated corneas had been used.

August 12, 2022
·
2 min read
·
Tristan Manalac